nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0946	0.248	CbGbCtD
Imiquimod—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0717	0.188	CbGbCtD
Imiquimod—CYP3A4—Betamethasone—ankylosing spondylitis	0.0615	0.161	CbGbCtD
Imiquimod—CYP3A4—Prednisolone—ankylosing spondylitis	0.0607	0.159	CbGbCtD
Imiquimod—CYP3A4—Prednisone—ankylosing spondylitis	0.0573	0.15	CbGbCtD
Imiquimod—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0358	0.0937	CbGbCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.00645	0.0749	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00504	0.0584	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.00489	0.0567	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00382	0.0443	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.0038	0.0441	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KIR3DL1—ankylosing spondylitis	0.00335	0.0389	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CARD9—ankylosing spondylitis	0.00302	0.0351	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00297	0.0344	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00294	0.0341	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.00288	0.0334	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KIR3DL1—ankylosing spondylitis	0.00254	0.0295	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CARD9—ankylosing spondylitis	0.00229	0.0266	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00225	0.0261	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00222	0.0258	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1R2—ankylosing spondylitis	0.00203	0.0235	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ERAP1—ankylosing spondylitis	0.00192	0.0223	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HLA-C—ankylosing spondylitis	0.0019	0.022	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.0018	0.0208	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CARD9—ankylosing spondylitis	0.00176	0.0204	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1R2—ankylosing spondylitis	0.00154	0.0178	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ERAP1—ankylosing spondylitis	0.00146	0.0169	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HLA-C—ankylosing spondylitis	0.00144	0.0167	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.0014	0.0163	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.00136	0.0158	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CARD9—ankylosing spondylitis	0.00133	0.0155	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HLA-B—ankylosing spondylitis	0.00112	0.013	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-C—ankylosing spondylitis	0.00111	0.0128	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.00106	0.0123	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—ankylosing spondylitis	0.000992	0.0115	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1RN—ankylosing spondylitis	0.00096	0.0111	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—ankylosing spondylitis	0.000951	0.011	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000932	0.0108	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HLA-B—ankylosing spondylitis	0.00085	0.00986	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD79A—ankylosing spondylitis	0.000843	0.00978	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-C—ankylosing spondylitis	0.000838	0.00972	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000795	0.00149	CcSEcCtD
Imiquimod—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000795	0.00149	CcSEcCtD
Imiquimod—Discomfort—Triamcinolone—ankylosing spondylitis	0.000794	0.00149	CcSEcCtD
Imiquimod—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000792	0.00149	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000791	0.00149	CcSEcCtD
Imiquimod—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000786	0.00148	CcSEcCtD
Imiquimod—Angioedema—Betamethasone—ankylosing spondylitis	0.000783	0.00147	CcSEcCtD
Imiquimod—Angioedema—Dexamethasone—ankylosing spondylitis	0.000783	0.00147	CcSEcCtD
Imiquimod—Angiopathy—Prednisone—ankylosing spondylitis	0.000778	0.00146	CcSEcCtD
Imiquimod—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000776	0.00146	CcSEcCtD
Imiquimod—Immune system disorder—Prednisone—ankylosing spondylitis	0.000774	0.00146	CcSEcCtD
Imiquimod—Malaise—Dexamethasone—ankylosing spondylitis	0.000773	0.00145	CcSEcCtD
Imiquimod—Malaise—Betamethasone—ankylosing spondylitis	0.000773	0.00145	CcSEcCtD
Imiquimod—Oedema—Triamcinolone—ankylosing spondylitis	0.000771	0.00145	CcSEcCtD
Imiquimod—Syncope—Dexamethasone—ankylosing spondylitis	0.000768	0.00144	CcSEcCtD
Imiquimod—Syncope—Betamethasone—ankylosing spondylitis	0.000768	0.00144	CcSEcCtD
Imiquimod—Arrhythmia—Prednisone—ankylosing spondylitis	0.000766	0.00144	CcSEcCtD
Imiquimod—Infection—Triamcinolone—ankylosing spondylitis	0.000766	0.00144	CcSEcCtD
Imiquimod—Infection—Methylprednisolone—ankylosing spondylitis	0.000764	0.00144	CcSEcCtD
Imiquimod—Shock—Triamcinolone—ankylosing spondylitis	0.000758	0.00143	CcSEcCtD
Imiquimod—Insomnia—Prednisolone—ankylosing spondylitis	0.000758	0.00142	CcSEcCtD
Imiquimod—Alopecia—Prednisone—ankylosing spondylitis	0.000757	0.00142	CcSEcCtD
Imiquimod—Shock—Methylprednisolone—ankylosing spondylitis	0.000756	0.00142	CcSEcCtD
Imiquimod—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000755	0.00142	CcSEcCtD
Imiquimod—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000754	0.00142	CcSEcCtD
Imiquimod—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000753	0.00142	CcSEcCtD
Imiquimod—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000753	0.00142	CcSEcCtD
Imiquimod—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000752	0.00141	CcSEcCtD
Imiquimod—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000752	0.00141	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CRP—ankylosing spondylitis	0.000752	0.00872	CbGpPWpGaD
Imiquimod—Mental disorder—Prednisone—ankylosing spondylitis	0.000751	0.00141	CcSEcCtD
Imiquimod—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00075	0.00141	CcSEcCtD
Imiquimod—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000747	0.0014	CcSEcCtD
Imiquimod—Erythema—Prednisone—ankylosing spondylitis	0.000746	0.0014	CcSEcCtD
Imiquimod—Malnutrition—Prednisone—ankylosing spondylitis	0.000746	0.0014	CcSEcCtD
Imiquimod—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000745	0.0014	CcSEcCtD
Imiquimod—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000743	0.0014	CcSEcCtD
Imiquimod—Convulsion—Dexamethasone—ankylosing spondylitis	0.000742	0.0014	CcSEcCtD
Imiquimod—Convulsion—Betamethasone—ankylosing spondylitis	0.000742	0.0014	CcSEcCtD
Imiquimod—Hypertension—Dexamethasone—ankylosing spondylitis	0.00074	0.00139	CcSEcCtD
Imiquimod—Hypertension—Betamethasone—ankylosing spondylitis	0.00074	0.00139	CcSEcCtD
Imiquimod—Myalgia—Dexamethasone—ankylosing spondylitis	0.000729	0.00137	CcSEcCtD
Imiquimod—Myalgia—Betamethasone—ankylosing spondylitis	0.000729	0.00137	CcSEcCtD
Imiquimod—TLR7—Immune System—IL1RN—ankylosing spondylitis	0.000728	0.00844	CbGpPWpGaD
Imiquimod—Anxiety—Dexamethasone—ankylosing spondylitis	0.000727	0.00137	CcSEcCtD
Imiquimod—Anxiety—Betamethasone—ankylosing spondylitis	0.000727	0.00137	CcSEcCtD
Imiquimod—Discomfort—Betamethasone—ankylosing spondylitis	0.000721	0.00135	CcSEcCtD
Imiquimod—Discomfort—Dexamethasone—ankylosing spondylitis	0.000721	0.00135	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TLR4—ankylosing spondylitis	0.000721	0.00836	CbGpPWpGaD
Imiquimod—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00072	0.00135	CcSEcCtD
Imiquimod—Pain—Prednisolone—ankylosing spondylitis	0.000717	0.00135	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000716	0.00135	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000711	0.00134	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000707	0.00133	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000702	0.00132	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000702	0.00132	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000701	0.00132	CcSEcCtD
Imiquimod—Oedema—Betamethasone—ankylosing spondylitis	0.000699	0.00131	CcSEcCtD
Imiquimod—Oedema—Dexamethasone—ankylosing spondylitis	0.000699	0.00131	CcSEcCtD
Imiquimod—Insomnia—Triamcinolone—ankylosing spondylitis	0.000697	0.00131	CcSEcCtD
Imiquimod—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000695	0.00131	CcSEcCtD
Imiquimod—Infection—Dexamethasone—ankylosing spondylitis	0.000695	0.00131	CcSEcCtD
Imiquimod—Infection—Betamethasone—ankylosing spondylitis	0.000695	0.00131	CcSEcCtD
Imiquimod—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000692	0.0013	CcSEcCtD
Imiquimod—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000692	0.0013	CcSEcCtD
Imiquimod—TLR8—Immune System—IL1A—ankylosing spondylitis	0.000691	0.00802	CbGpPWpGaD
Imiquimod—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000691	0.0013	CcSEcCtD
Imiquimod—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00069	0.0013	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—ankylosing spondylitis	0.00069	0.0013	CcSEcCtD
Imiquimod—Shock—Dexamethasone—ankylosing spondylitis	0.000688	0.00129	CcSEcCtD
Imiquimod—Shock—Betamethasone—ankylosing spondylitis	0.000688	0.00129	CcSEcCtD
Imiquimod—TLR8—Immune System—CD40LG—ankylosing spondylitis	0.000687	0.00797	CbGpPWpGaD
Imiquimod—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000687	0.00129	CcSEcCtD
Imiquimod—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000686	0.00129	CcSEcCtD
Imiquimod—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000686	0.00129	CcSEcCtD
Imiquimod—Agitation—Prednisone—ankylosing spondylitis	0.000686	0.00129	CcSEcCtD
Imiquimod—Tachycardia—Betamethasone—ankylosing spondylitis	0.000682	0.00128	CcSEcCtD
Imiquimod—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000682	0.00128	CcSEcCtD
Imiquimod—Angioedema—Prednisone—ankylosing spondylitis	0.000682	0.00128	CcSEcCtD
Imiquimod—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000678	0.00128	CcSEcCtD
Imiquimod—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000677	0.00127	CcSEcCtD
Imiquimod—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000677	0.00127	CcSEcCtD
Imiquimod—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000676	0.00127	CcSEcCtD
Imiquimod—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000676	0.00127	CcSEcCtD
Imiquimod—Malaise—Prednisone—ankylosing spondylitis	0.000673	0.00126	CcSEcCtD
Imiquimod—Eye disorder—Methotrexate—ankylosing spondylitis	0.000669	0.00126	CcSEcCtD
Imiquimod—Syncope—Prednisone—ankylosing spondylitis	0.000669	0.00126	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—ankylosing spondylitis	0.000668	0.00126	CcSEcCtD
Imiquimod—Anorexia—Dexamethasone—ankylosing spondylitis	0.000666	0.00125	CcSEcCtD
Imiquimod—Anorexia—Betamethasone—ankylosing spondylitis	0.000666	0.00125	CcSEcCtD
Imiquimod—Urticaria—Prednisolone—ankylosing spondylitis	0.000666	0.00125	CcSEcCtD
Imiquimod—Fatigue—Triamcinolone—ankylosing spondylitis	0.000664	0.00125	CcSEcCtD
Imiquimod—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000663	0.00125	CcSEcCtD
Imiquimod—Pain—Triamcinolone—ankylosing spondylitis	0.000659	0.00124	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000656	0.00123	CcSEcCtD
Imiquimod—TLR8—Immune System—HLA-B—ankylosing spondylitis	0.000654	0.00758	CbGpPWpGaD
Imiquimod—Angiopathy—Methotrexate—ankylosing spondylitis	0.00065	0.00122	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000647	0.00122	CcSEcCtD
Imiquimod—Convulsion—Prednisone—ankylosing spondylitis	0.000646	0.00122	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000646	0.00121	CcSEcCtD
Imiquimod—Hypertension—Prednisone—ankylosing spondylitis	0.000644	0.00121	CcSEcCtD
Imiquimod—Chills—Methotrexate—ankylosing spondylitis	0.000643	0.00121	CcSEcCtD
Imiquimod—TLR7—Immune System—CD79A—ankylosing spondylitis	0.000639	0.00741	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000637	0.0012	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000637	0.0012	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—ankylosing spondylitis	0.000635	0.00119	CcSEcCtD
Imiquimod—Myalgia—Prednisone—ankylosing spondylitis	0.000635	0.00119	CcSEcCtD
Imiquimod—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000635	0.00119	CcSEcCtD
Imiquimod—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000634	0.00119	CcSEcCtD
Imiquimod—Anxiety—Prednisone—ankylosing spondylitis	0.000633	0.00119	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—ankylosing spondylitis	0.000633	0.00119	CcSEcCtD
Imiquimod—Insomnia—Betamethasone—ankylosing spondylitis	0.000632	0.00119	CcSEcCtD
Imiquimod—Insomnia—Dexamethasone—ankylosing spondylitis	0.000632	0.00119	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000631	0.00119	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000629	0.00118	CcSEcCtD
Imiquimod—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000628	0.00118	CcSEcCtD
Imiquimod—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000628	0.00118	CcSEcCtD
Imiquimod—Discomfort—Prednisone—ankylosing spondylitis	0.000628	0.00118	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—ankylosing spondylitis	0.000628	0.00118	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—ankylosing spondylitis	0.000624	0.00117	CcSEcCtD
Imiquimod—Erythema—Methotrexate—ankylosing spondylitis	0.000624	0.00117	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000617	0.00116	CcSEcCtD
Imiquimod—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000615	0.00116	CcSEcCtD
Imiquimod—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000615	0.00116	CcSEcCtD
Imiquimod—Urticaria—Triamcinolone—ankylosing spondylitis	0.000612	0.00115	CcSEcCtD
Imiquimod—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000611	0.00115	CcSEcCtD
Imiquimod—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000609	0.00115	CcSEcCtD
Imiquimod—Oedema—Prednisone—ankylosing spondylitis	0.000609	0.00114	CcSEcCtD
Imiquimod—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000608	0.00114	CcSEcCtD
Imiquimod—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000608	0.00114	CcSEcCtD
Imiquimod—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000608	0.00114	CcSEcCtD
Imiquimod—TLR8—Immune System—HLA-A—ankylosing spondylitis	0.000606	0.00702	CbGpPWpGaD
Imiquimod—Infection—Prednisone—ankylosing spondylitis	0.000605	0.00114	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000604	0.00113	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000604	0.00113	CcSEcCtD
Imiquimod—Back pain—Methotrexate—ankylosing spondylitis	0.000603	0.00113	CcSEcCtD
Imiquimod—Fatigue—Betamethasone—ankylosing spondylitis	0.000603	0.00113	CcSEcCtD
Imiquimod—Fatigue—Dexamethasone—ankylosing spondylitis	0.000603	0.00113	CcSEcCtD
Imiquimod—Shock—Prednisone—ankylosing spondylitis	0.000599	0.00113	CcSEcCtD
Imiquimod—Pain—Betamethasone—ankylosing spondylitis	0.000598	0.00112	CcSEcCtD
Imiquimod—Pain—Dexamethasone—ankylosing spondylitis	0.000598	0.00112	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000597	0.00112	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—ankylosing spondylitis	0.000594	0.00112	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—ankylosing spondylitis	0.000591	0.00111	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000589	0.00111	CcSEcCtD
Imiquimod—Anorexia—Prednisone—ankylosing spondylitis	0.00058	0.00109	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000579	0.00109	CcSEcCtD
Imiquimod—TLR8—Immune System—CRP—ankylosing spondylitis	0.000578	0.0067	CbGpPWpGaD
Imiquimod—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000576	0.00108	CcSEcCtD
Imiquimod—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000576	0.00108	CcSEcCtD
Imiquimod—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000572	0.00107	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000572	0.00107	CcSEcCtD
Imiquimod—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000568	0.00107	CcSEcCtD
Imiquimod—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000566	0.00106	CcSEcCtD
Imiquimod—Malaise—Methotrexate—ankylosing spondylitis	0.000562	0.00106	CcSEcCtD
Imiquimod—Urticaria—Betamethasone—ankylosing spondylitis	0.000555	0.00104	CcSEcCtD
Imiquimod—Urticaria—Dexamethasone—ankylosing spondylitis	0.000555	0.00104	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000555	0.00104	CcSEcCtD
Imiquimod—Dizziness—Prednisolone—ankylosing spondylitis	0.000554	0.00104	CcSEcCtD
Imiquimod—TLR8—Immune System—TLR4—ankylosing spondylitis	0.000554	0.00642	CbGpPWpGaD
Imiquimod—Asthenia—Triamcinolone—ankylosing spondylitis	0.000553	0.00104	CcSEcCtD
Imiquimod—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000553	0.00104	CcSEcCtD
Imiquimod—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000553	0.00104	CcSEcCtD
Imiquimod—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000553	0.00104	CcSEcCtD
Imiquimod—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000553	0.00104	CcSEcCtD
Imiquimod—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000552	0.00104	CcSEcCtD
Imiquimod—Insomnia—Prednisone—ankylosing spondylitis	0.000551	0.00104	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—ankylosing spondylitis	0.000547	0.00103	CcSEcCtD
Imiquimod—Pruritus—Triamcinolone—ankylosing spondylitis	0.000545	0.00102	CcSEcCtD
Imiquimod—Cough—Methotrexate—ankylosing spondylitis	0.000544	0.00102	CcSEcCtD
Imiquimod—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000544	0.00102	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—ankylosing spondylitis	0.00054	0.00102	CcSEcCtD
Imiquimod—Dyspepsia—Prednisone—ankylosing spondylitis	0.000536	0.00101	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—ankylosing spondylitis	0.000531	0.000998	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—ankylosing spondylitis	0.000531	0.000998	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—ankylosing spondylitis	0.000531	0.000998	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—ankylosing spondylitis	0.000529	0.000995	CcSEcCtD
Imiquimod—Rash—Prednisolone—ankylosing spondylitis	0.000528	0.000993	CcSEcCtD
Imiquimod—Dermatitis—Prednisolone—ankylosing spondylitis	0.000528	0.000992	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000527	0.000991	CcSEcCtD
Imiquimod—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000526	0.000989	CcSEcCtD
Imiquimod—Fatigue—Prednisone—ankylosing spondylitis	0.000525	0.000987	CcSEcCtD
Imiquimod—Headache—Prednisolone—ankylosing spondylitis	0.000525	0.000987	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—ankylosing spondylitis	0.000524	0.000986	CcSEcCtD
Imiquimod—TLR7—Immune System—IL1A—ankylosing spondylitis	0.000524	0.00608	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40LG—ankylosing spondylitis	0.000521	0.00604	CbGpPWpGaD
Imiquimod—Dizziness—Triamcinolone—ankylosing spondylitis	0.00051	0.000958	CcSEcCtD
Imiquimod—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000508	0.000956	CcSEcCtD
Imiquimod—Infection—Methotrexate—ankylosing spondylitis	0.000506	0.00095	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000502	0.000943	CcSEcCtD
Imiquimod—Asthenia—Betamethasone—ankylosing spondylitis	0.000502	0.000943	CcSEcCtD
Imiquimod—Asthenia—Dexamethasone—ankylosing spondylitis	0.000502	0.000943	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000499	0.000938	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000498	0.000936	CcSEcCtD
Imiquimod—Nausea—Prednisolone—ankylosing spondylitis	0.000498	0.000936	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-B—ankylosing spondylitis	0.000495	0.00575	CbGpPWpGaD
Imiquimod—Pruritus—Dexamethasone—ankylosing spondylitis	0.000495	0.00093	CcSEcCtD
Imiquimod—Pruritus—Betamethasone—ankylosing spondylitis	0.000495	0.00093	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—ankylosing spondylitis	0.000494	0.000929	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000492	0.000925	CcSEcCtD
Imiquimod—Vomiting—Triamcinolone—ankylosing spondylitis	0.00049	0.000921	CcSEcCtD
Imiquimod—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000489	0.000919	CcSEcCtD
Imiquimod—Rash—Triamcinolone—ankylosing spondylitis	0.000486	0.000913	CcSEcCtD
Imiquimod—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000485	0.000912	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—ankylosing spondylitis	0.000485	0.000912	CcSEcCtD
Imiquimod—Rash—Methylprednisolone—ankylosing spondylitis	0.000485	0.000911	CcSEcCtD
Imiquimod—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000484	0.00091	CcSEcCtD
Imiquimod—Urticaria—Prednisone—ankylosing spondylitis	0.000484	0.000909	CcSEcCtD
Imiquimod—Headache—Triamcinolone—ankylosing spondylitis	0.000483	0.000907	CcSEcCtD
Imiquimod—Headache—Methylprednisolone—ankylosing spondylitis	0.000482	0.000905	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—ankylosing spondylitis	0.000481	0.000905	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—ankylosing spondylitis	0.000481	0.000905	CcSEcCtD
Imiquimod—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000478	0.000899	CcSEcCtD
Imiquimod—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000478	0.000899	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000464	0.000871	CcSEcCtD
Imiquimod—Dizziness—Betamethasone—ankylosing spondylitis	0.000462	0.000869	CcSEcCtD
Imiquimod—Dizziness—Dexamethasone—ankylosing spondylitis	0.000462	0.000869	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—ankylosing spondylitis	0.00046	0.000865	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-A—ankylosing spondylitis	0.000459	0.00532	CbGpPWpGaD
Imiquimod—Nausea—Triamcinolone—ankylosing spondylitis	0.000458	0.00086	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000457	0.000859	CcSEcCtD
Imiquimod—Nausea—Methylprednisolone—ankylosing spondylitis	0.000457	0.000858	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000454	0.000853	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—ankylosing spondylitis	0.000452	0.00085	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000449	0.000843	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000448	0.000842	CcSEcCtD
Imiquimod—Vomiting—Dexamethasone—ankylosing spondylitis	0.000445	0.000836	CcSEcCtD
Imiquimod—Vomiting—Betamethasone—ankylosing spondylitis	0.000445	0.000836	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000442	0.000832	CcSEcCtD
Imiquimod—Rash—Betamethasone—ankylosing spondylitis	0.000441	0.000829	CcSEcCtD
Imiquimod—Rash—Dexamethasone—ankylosing spondylitis	0.000441	0.000829	CcSEcCtD
Imiquimod—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00044	0.000828	CcSEcCtD
Imiquimod—Dermatitis—Betamethasone—ankylosing spondylitis	0.00044	0.000828	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000439	0.000826	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—ankylosing spondylitis	0.000439	0.000825	CcSEcCtD
Imiquimod—Headache—Betamethasone—ankylosing spondylitis	0.000438	0.000823	CcSEcCtD
Imiquimod—Headache—Dexamethasone—ankylosing spondylitis	0.000438	0.000823	CcSEcCtD
Imiquimod—TLR7—Immune System—CRP—ankylosing spondylitis	0.000438	0.00508	CbGpPWpGaD
Imiquimod—Asthenia—Prednisone—ankylosing spondylitis	0.000437	0.000821	CcSEcCtD
Imiquimod—Pain—Methotrexate—ankylosing spondylitis	0.000435	0.000818	CcSEcCtD
Imiquimod—Pruritus—Prednisone—ankylosing spondylitis	0.000431	0.00081	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR4—ankylosing spondylitis	0.00042	0.00487	CbGpPWpGaD
Imiquimod—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000419	0.000788	CcSEcCtD
Imiquimod—Diarrhoea—Prednisone—ankylosing spondylitis	0.000417	0.000783	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000416	0.000782	CcSEcCtD
Imiquimod—Nausea—Betamethasone—ankylosing spondylitis	0.000415	0.000781	CcSEcCtD
Imiquimod—Nausea—Dexamethasone—ankylosing spondylitis	0.000415	0.000781	CcSEcCtD
Imiquimod—Urticaria—Methotrexate—ankylosing spondylitis	0.000404	0.00076	CcSEcCtD
Imiquimod—Dizziness—Prednisone—ankylosing spondylitis	0.000403	0.000757	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000402	0.000756	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000402	0.000756	CcSEcCtD
Imiquimod—Vomiting—Prednisone—ankylosing spondylitis	0.000387	0.000728	CcSEcCtD
Imiquimod—Rash—Prednisone—ankylosing spondylitis	0.000384	0.000722	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—ankylosing spondylitis	0.000384	0.000721	CcSEcCtD
Imiquimod—Headache—Prednisone—ankylosing spondylitis	0.000381	0.000717	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000375	0.000705	CcSEcCtD
Imiquimod—Asthenia—Methotrexate—ankylosing spondylitis	0.000365	0.000686	CcSEcCtD
Imiquimod—Nausea—Prednisone—ankylosing spondylitis	0.000362	0.00068	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—ankylosing spondylitis	0.00036	0.000677	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000348	0.000654	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—ankylosing spondylitis	0.000337	0.000633	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—ankylosing spondylitis	0.000324	0.000608	CcSEcCtD
Imiquimod—Rash—Methotrexate—ankylosing spondylitis	0.000321	0.000603	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—ankylosing spondylitis	0.000321	0.000603	CcSEcCtD
Imiquimod—Headache—Methotrexate—ankylosing spondylitis	0.000319	0.000599	CcSEcCtD
Imiquimod—Nausea—Methotrexate—ankylosing spondylitis	0.000302	0.000568	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000259	0.00301	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000259	0.00301	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	8.83e-05	0.00102	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	6.82e-05	0.000791	CbGpPWpGaD
